EXPRESSION OF PRO AND ANTIINFLAMMATORY CYTOKINES DURING ANTIPCSK9 THERAPY IN PATIENTS WITH STATIN RESISTANT FAMILIAL HYPERCHOLESTEROLEMIA

被引：0
|
作者：
Suarez-Cuenca, Juan Antonio [1 ]
Morales Portano, Julieta [1 ]
Bricia Margarita, Roa-Martinez [1 ]
De Vaca Rebeca, Perez-Cabeza [1 ]
Rafael, Trujillo-Cortes [1 ]
机构：
[1] Ctr Med Nacl 20 Noviembre ISSSTE, Mexico City, DF, Mexico
来源：
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY | 2024年 / 83卷 / 13期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1545-144
引用
收藏
页码：1347 / 1347
页数：1
相关论文
共 50 条
  • [31] Expression of cytokines in patients with hepatitis C virus during anti-viral therapy
    Cordero, P
    Ramirez, AC
    Munoz, L
    GASTROENTEROLOGY, 2003, 124 (04) : A741 - A741
  • [32] Rescue therapy with PCSK9 inhibitors for patients with delayed diagnosis of heterozygous familial hypercholesterolemia: Redressing the balance of missed opportunities
    Vuorio, Alpo
    Watts, Gerald F.
    Kovanen, Petri T.
    JOURNAL OF CLINICAL LIPIDOLOGY, 2016, 10 (05) : 1278 - 1279
  • [33] LDL-cholesterol and PCSK9 in patients with familial hypercholesterolemia: influence of PCSK9 variants under lipid-lowering therapy
    Hamasaki, Masato
    Sakane, Naoki
    Hara, Kazuo
    Kotani, Kazuhiko
    JOURNAL OF CLINICAL LABORATORY ANALYSIS, 2021, 35 (11)
  • [34] Target achievement with maximal statin-based lipid-lowering therapy in Korean patients with familial hypercholesterolemia: A study supported by the Korean Society of Lipid and Atherosclerosis
    Oh, Jaewon
    Lee, Chan Joo
    Kim, Doo Il
    Rhee, Moo-Yong
    Lee, Byoung-Kwon
    Ahn, Youngkeun
    Cho, Byung Ryul
    Woo, Jeong-Taek
    Hur, Seung-Ho
    Jeong, Jin-Ok
    Jang, Yangsoo
    Lee, Sang-Hak
    CLINICAL CARDIOLOGY, 2017, 40 (12) : 1291 - 1296
  • [35] Therapeutic efficacy and safety of PCSK9-monoclonal antibodies on familial hypercholesterolemia and statin-intolerant patients: A meta-analysis of 15 randomized controlled trials
    Li Jun Qian
    Yao Gao
    Yan Mei Zhang
    Ming Chu
    Jing Yao
    Di Xu
    Scientific Reports, 7
  • [36] Therapeutic efficacy and safety of PCSK9-monoclonal antibodies on familial hypercholesterolemia and statin-intolerant patients: A meta-analysis of 15 randomized controlled trials
    Qian, Li Jun
    Gao, Yao
    Zhang, Yan Mei
    Chu, Ming
    Yao, Jing
    Xu, Di
    SCIENTIFIC REPORTS, 2017, 7
  • [37] Endothelial function improvement in patients with familial hypercholesterolemia receiving PCSK-9 inhibitors on top of maximally tolerated lipid lowering therapy
    Minno, Alessandro Di
    Gentile, Marco
    Iannuzzo, Gabriella
    Calcaterra, Ilenia
    Tripaldella, Maria
    Porro, Benedetta
    Cavalca, Viviana
    Taranto, Maria Donata Di
    Tremoli, Elena
    Fortunato, Giuliana
    Rubba, Paolo Osvaldo Federico
    Di Minno, Matteo Nicola Dario
    THROMBOSIS RESEARCH, 2020, 194 : 229 - 236
  • [38] Impact of evolocumab, a PCSK9 inhibitor, withdrawing from regular ldl-apheresis therapy in patients with heterozygous familial hypercholesterolemia
    Kawashiri, M.
    Higashikata, T.
    Nohara, A.
    Nakanishi, C.
    Tada, H.
    Okada, H.
    Yamagishi, M.
    EUROPEAN HEART JOURNAL, 2017, 38 : 1331 - 1331
  • [39] Effectiveness and safety of PCSK9 inhibitor therapy in patients with familial hypercholesterolemia within a therapeutic program in Poland: Preliminary multicenter data
    Chlebus, Krzysztof
    Cybulska, Barbara
    Dobrowolski, Piotr
    Romanowska-Kocejko, Marzena
    Zarczynska-Buchowiecka, Marta
    Gilis-Malinowska, Natasza
    Strozyk, Aneta
    Borowiec-Wolna, Justyna
    Pajkowski, Marcin
    Bobrowska, Beata
    Rajtar-Salwa, Renata
    Kwapiszewska, Aleksandra
    Walus-Miarka, Malgorzata
    Chmara, Magdalena
    Galaska, Rafal
    Malecki, Maciej
    Zdrojewski, Tomasz
    Gruchala, Marcin
    CARDIOLOGY JOURNAL, 2022, 29 (01) : 62 - 71
  • [40] Expression of cytokines in patients with hepatitis C virus during anit-viral therapy.
    Cordero, P
    Casillas, A
    Díaz, V
    Rodríguez, M
    Muñoz, L
    HEPATOLOGY, 2002, 36 (04) : 478A - 478A
12345